Indefinite Delivery Contract SPE2DX18D9539

The federal contract IDV award SPE2DX18D9539 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which is valid through December 31, 2025, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The contract covers a diverse portfolio of pharmaceutical items across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.

The task orders awarded under this IDC, SPE2DX23FY774 and SPE2DX22FY774, have ceiling values of $20.00 and $8.00, respectively, and are for the delivery of pharmaceutical products to the Medical Supply Chain division of the DLA. These delivery orders are firm fixed-price contracts, with the place of performance being DMS Pharmaceutical Group's facility in Park Ridge, Illinois. The contract aims to provide a reliable and comprehensive source of pharmaceutical products to support the medical readiness and healthcare needs of the U.S. Department of Defense.